Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Why QoL Measures Change TED Management
Kimberly Cockerham, MD
Overcoming Real-World Barriers to TED Treatment
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Why Staging TED Correctly Matters Even When CAS Is Low
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Steven Yeh, MD, FASRS
Vitreous Sensing Vitrectomy
Maria Berrocal
Jordan D. Deaner, MD
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.